BioSpace News Archive

FDA

Novartis announces FDA approval of MET inhibitor Tabrecta™ for metastatic non-small cell lung cancer with METex14

Tabrecta (capmatinib, formerly INC280) is the first and only therapy approved by the FDA to specifically target metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14)(1)

May 6, 2020
·
14 min read
Business

Evolus to Report First Quarter 2020 Financial Results and Provide a Business Update on Monday, May 11, 2020

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced that it will report its first quarter 2020 financial results and provide a business update on Monday, May 11, 2020 after the close of the U.S. financial markets.

May 6, 2020
·
1 min read
Business

TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020

TRACON Pharmaceuticals announced that it will report its first quarter 2020 financial and operating results after the close of U.S. financial markets on Wednesday, May 13, 2020.

May 6, 2020
·
1 min read
Business

ADMA Biologics Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress

ADMA Biologics, Inc. reported financial results for the quarter ended March 31, 2020, ADMA’s first fiscal quarter, and provided an overview of recent progress and accomplishments.

May 6, 2020
·
13 min read
Business

SeaSpine Reports First Quarter 2020 Financial Results

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced financial results for the three-months ended March 31, 2020.

May 6, 2020
·
8 min read
Business

Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, reported financial results for the three months ended March 31, 2020.

May 6, 2020
·
25 min read
Business

Morphic Announces Corporate Highlights and First Quarter 2020 Financial Results

Morphic Therapeutic, a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, reported corporate highlights and first quarter 2020 financial results.

May 6, 2020
·
6 min read
Business

BioTelemetry, Inc. Reports First Quarter 2020 Financial ResultsAnnounces Record Quarterly Revenue

BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, reported results for the quarter ended March 31, 2020.

May 6, 2020
·
9 min read
Business

TransMedics Reports First Quarter 2020 Financial Results

TransMedics Group, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, reported financial results for the quarter ended March 31, 2020.

May 6, 2020
·
5 min read
Business

OPKO Health Reports 2020 First Quarter Business Highlights and Financial ResultsConference call begins at 4:30 p.m. Eastern time today

OPKO Health, Inc. reports business highlights and financial results for the three months ended March 31, 2020.

May 6, 2020
·
11 min read